Financials
Financial year 2025
Gross margin
€ 2 million
▲ 28% vs 2024
Profit
Growing€ 584,413
▲ 150% vs 2024
Debts
Low€ 667,513
▲ 127% vs 2024
ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND from Meise, company number BE0535868481, closed financial year 2025 with a result of € 584,413 after tax. For that financial year ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND recorded a gross margin of € 2 million and equity of € 5.3 million. Compared with financial year 2024, the result moved from € 233,594 to € 584,413. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 17, 2026.
What happened at ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND?
What happened at ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 584,413 (▲ 150% vs 2024). Source: NBB ↗
- Johan VAN BIESBROECK stepped down as director. NBB
- Alice DOSSCHE became a director. NBB
- Luc TAYART de Borms became a director. NBB
- Rudy DEKEYSER became a director. NBB
- Johan VAN BIESBROECK became a director. NBB
- New establishment in Meise. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,001 loss in 2021 to € 584,413 profit in 2025.
Paid € 65,828 in corporate taxes since 2021.
Best year ever: 2025, with € 584,413 profit.
On average € 174,600 of value added per employee in 2025.
A new publication or filing at ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND? We notify you, reason included.
Follow ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUNDNeed more data?
History
Every financial year, as far back as the National Bank goes.
Buffer
How long does the company survive without income?
Credit limit
Indicative credit limit, computed from the real figures.
Alerts
News about who you follow, reason included.
Then €29.99/mo excl. VAT, cancel monthly. No credit card to try; the AI assistant is not included, or only in a very limited form, during the trial month. Sign up now and you’ll be invited first.
Management
Behind ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND are Alice DOSSCHE, Luc TAYART de Borms, Lydie MEHEUS, Rudy DEKEYSER and Luc VERELST. The same people are also behind Journalismfund Europe, reMYND, R.A.D. LIFE SCIENCES, Health Economics Privak II and LSP 6 Privak.
Directors
According to the 2025 annual accounts
Alice DOSSCHE
Director
since 2022
since 2022
Lydie MEHEUS
Managing director
since 2013
Rudy DEKEYSER
Director
Also active at: reMYND, R.A.D. LIFE SCIENCES, Health Economics Privak II +6 more
since 2022
since 2013
since 2015 · until 2025
Establishments
Establishment units
Physical locations of this company
Brusselsesteenweg 11
1860 Meise
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0535.868.481
- VAT number
- BE 0535.868.481
- Registered office
- Brusselsesteenweg 11, 1860 Meise
- Names & denominations
- ANTIKANKERFONDS-FONDS ANTICANCER-ANTICANCER FUND
- Enterprise type
- Rechtspersoon
- Legal form
- Public-interest foundation
- Legal situation
- Normale toestand
- Start date
- 21 June 2013
- Peppol
- Active · Active since 23 Oct 2025
- Activities · NACE
Verenigingen op het vlak van ziektepreventie en gezondheidsbevordering
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overige activiteiten van vrije beroepen en andere wetenschappelijke en technische activiteiten, neg
Overige gespecialiseerde wetenschappelijke en technische activiteiten